Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 136 Head and Neck Neoplasms 96 Squamous Cell Carcinoma of Head and Neck 89 Carcinoma, Non-Small-Cell Lung 58 Colonic Neoplasms 44 Rectal Neoplasms 38 Neoplasm Metastasis 34 Neoplasms 28 Pancreatic Neoplasms 24 Lung Neoplasms 18 Carcinoma, Squamous Cell 18 Stomach Neoplasms 15 Tongue Neoplasms 13 Esophageal Neoplasms 13 Salivary Gland Neoplasms 11 Recurrence 10 Breast Neoplasms 10 Laryngeal Neoplasms 9 Mouth Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Carcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma of Lung 7 Neoplasms, Squamous Cell 6 Hypopharyngeal Neoplasms 6 Carcinoma, Renal Cell 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Oropharyngeal Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Hepatocellular 5

Interventions

Saline Solution 1 Lidocaine 1 Cyproterone Acetate 1 Cetuximab 1 Adrenal Cortex Hormones 1 Adalimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Acne Vulgaris × Cetuximab × Clear all

NCT01382407 2017-04-27

Does Acne Rash During Adolescence Predict Skin Reaction to Cetuximab

Rambam Health Care Campus

Acne Vulgaris

Data powered by HemOnc (CC BY 4.0) Colophon ⚡